International Trade Commission October 16, 2012 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Certain Reduced Folate Nutraceutical Products and L-Methylfolate Raw Ingredients Used Therein; Institution of Investigation Pursuant to United States Code
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on September 10, 2012, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of South Alabama Medical Science Foundation of Mobile, Alabama; Merck & Cie of Switzerland; and Pamlab LLC of Covington, Louisiana. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain reduced folate nutraceutical products and l-methylfolate raw ingredients used therein by reason of infringement of certain claims of U.S. Patent No. 5,997,915 (``the `915 patent''); U.S. Patent No. 6,673,381 (``the `381 patent''); U.S. Patent No. 7,172,778 (``the `778 patent''); and U.S. Patent No. 6,011,040 (``the `040 patent''). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainants request that the Commission institute an investigation and, after the investigation, issue an exclusion order and cease and desist orders.